{"article_title": "Baltimore offers glimpse of broader opioid treatment planned in R.I.", "article_keywords": ["opioid", "delivered", "glimpse", "right", "community", "sign", "offers", "inbox", "planned", "broader", "headlines", "newsletter", "ri", "baltimore", "treatment"], "article_url": "http://www.providencejournal.com/article/20160507/NEWS/160509420", "article_text": "Sign up for our newsletter and have the top headlines from your community delivered right to your inbox", "article_metadata": {"description": "Collaborative program also offers the two other federally approved addiction medications, buprenorphine and naltrexone, and a full complement of mandatory addiction counseling and group classes.", "vf": {"unique_id": "art-3169A19A-CCB8-3322-E053-0100007F05AB-pub2711"}, "author": "Christine Vestal Stateline.org", "og": {"type": "article", "image": {"width": 1024, "identifier": "http://www.providencejournal.com/storyimage/PJ/20160507/NEWS/160509420/AR/0/AR-160509420.jpg", "height": 576}, "site_name": "providencejournal.com", "description": "Collaborative program also offers the two other federally approved addiction medications, buprenorphine and naltrexone, and a full complement of mandatory", "title": "Baltimore offers glimpse of broader opioid treatment planned in R.I."}, "twitter": {"site": "@projo", "image": {"src": "http://www.providencejournal.com/storyimage/PJ/20160507/NEWS/160509420/AR/0/AR-160509420.jpg&MaxW=1200&MaxH=630"}, "description": "Collaborative program also offers the two other federally approved addiction medications, buprenorphine and naltrexone, and a full complement of mandatory addiction counseling and group classes.", "card": "summary_large_image", "title": "Baltimore offers glimpse of broader opioid treatment planned in R.I."}, "msapplication-TileColor": "#063b72", "metered": "true", "bt": {"author": "Christine Vestal Stateline.org", "pubDate": "20160508T01:27:58Z", "modDate": "20160508T01:27:00Z"}, "fb": {"app_id": 139309856150185}, "tout": {"article": {"id": "art-3169A19A-CCB8-3322-E053-0100007F05AB-pub2711"}}, "msapplication-TileImage": "/Global/images/favicons/providencejournal/mstile-144x144.png", "msvalidate.01": "7E15F9269E2CE66F2A488ABB04B5015E", "theme-color": "#ffffff"}, "article_summary": "Sign up for our newsletter and have the top headlines from your community delivered right to your inbox"}